News

Supporting cancer research with IP rights

April 30, 2019/in External, News /by oslocancer

Why are legal services an important part of Oslo Cancer Cluster? We asked Andrew Wright from Potter Clarkson to explain why they became a member.

Ny rapport: Helsenæringens verdi 2019

April 25, 2019/in Helsenæring, Helsenæringens verdi, News, Oslo Cancer Cluster /by oslocancer

Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.

Meet our new members

April 25, 2019/in Members, News, Oslo Cancer Cluster /by oslocancer

Oslo Cancer Cluster proudly presents the new members who have joined our organisation during the first quarter of 2019.

The first Norwegian CAR

April 8, 2019/in cancer research, CAR T cells, Immuno-Oncology, immunotherapy, News, Oslo Cancer Cluster Incubator /by oslocancer

Made in Oslo, the first ever Norwegian CAR T cell is now a fact.

Encouraging news from BerGenBio

April 3, 2019/in bemcentinib, bergenbio, External, immune checkpoint inhibitor, immunotherapy, KEYTRUDA, lung cancer, Members, new cancer treatment, News /by oslocancer

A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.

Giving patients a stronger voice

March 28, 2019/in health technology assessment, HTA, new cancer treatments, News, Oslo Cancer Cluster, patient involvement /by oslocancer

How can the voices of cancer patients be heard when evaluating new methods of treatment?